Levaquin and Ambrisentan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Levaquin (levofloxacin) and Ambrisentan (ambrisentan). Common drug interactions include dysphagia among females and fluid retention among males.

The phase IV clinical study analyzes what interactions people have when they take Levaquin and Ambrisentan. It is created by eHealthMe based on reports of 61 people who take the same drugs from the FDA, and is updated regularly.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.

What is Ambrisentan?

Ambrisentan has active ingredients of ambrisentan. eHealthMe is studying from 61,368 Ambrisentan users. Check the latest studies of Ambrisentan.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 14, 2026

61 people who take Levaquin and Ambrisentan together, and have interactions are studied.

Levaquin and Ambrisentan drug interactions.

What are the common drug interactions of Levaquin and Ambrisentan, by gender? *:

female:

Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea at rest (difficult or laboured breathing during rest)
Enterococcal infection
Faeces discoloured
Gastritis (inflammation of stomach)
Generalised erythema (redness of the skin all over the body)
Haematochezia (passage of stools containing blood)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Haemorrhagic cyst (bleeding cyst)
Hallucination (an experience involving the perception of something not present)

male:

Fluid retention (an abnormal accumulation of fluid in the blood)
Dyspnoea (difficult or laboured respiration)
Blood pressure decreased
Cough
Diarrhoea
Drug hypersensitivity
Dyspnoea exertional (breathlessness or shortness of breath)
Oedema (fluid collection in tissue)
Pain
Tibia fracture (fracture of lower leg bone)

What are the common drug interactions of Levaquin and Ambrisentan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Death
Drug hypersensitivity
Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
Vomiting

20-29:

n/a

30-39:

Back pain
Dyspnoea exertional (breathlessness or shortness of breath)
Loss of consciousness

40-49:

Fatigue (feeling of tiredness)
Headache (pain in head)
Asthma
Chest pain
Diarrhoea
Drug hypersensitivity
Hangover
Muscle spasms (muscle contraction)
Pain in extremity
Peripheral swelling

50-59:

Acute respiratory failure
Agitated depression
Anaemia (lack of blood)
Arthralgia (joint pain)
Atelectasis (partial or complete collapse of the lung)
Back pain
Bone pain
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Constipation
Decreased appetite

60+:

Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Anaemia (lack of blood)
Respiratory failure (inadequate gas exchange by the respiratory system)
Bedridden
Constipation
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Flatulence (flatus expelled through the anus)
Hypoaesthesia (reduced sense of touch or sensation)

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 27 people, 44.26%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 20 people, 32.79%

* Approximation only. Some reports may have incomplete information.

Do you take Levaquin and Ambrisentan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously